|
G-CSF (Filgrastim) Clinical Trials
2 actively recruiting trials
Also known as: Neupomax, Tevagrastim, Zarzio
Pipeline
Phase 2: 2
Top Sponsors
- Yaqrit Ltd1
- Blokhin's Russian Cancer Research Center1
Indications
- Alcoholic Hepatitis1
- Liver Cirrhosis, Alcoholic1
- Acute on Chronic Liver Failure1
- Liver Disease1
- Germ Cell Cancer Metastatic1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.